These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 6183818)

  • 1. The effect of proteolytic enzymes on the infectivity of vaccinia virus.
    Ichihashi Y; Tsuruhara T; Oie M
    Virology; 1982 Oct; 122(2):279-89. PubMed ID: 6183818
    [No Abstract]   [Full Text] [Related]  

  • 2. Biogenesis of vaccina: interrelationship between post-translational cleavage, virus assembly, and maturation.
    Silver M; Dales S
    Virology; 1982 Mar; 117(2):341-56. PubMed ID: 7039091
    [No Abstract]   [Full Text] [Related]  

  • 3. [Inductor of deproteinization enzyme of vaccinia virus nucleocapsid].
    Peterson OP; Kozlova IA
    Vopr Virusol; 1970; 15(2):156-61. PubMed ID: 5470913
    [No Abstract]   [Full Text] [Related]  

  • 4. Activation of Sendai virus infectivity by an enzyme in chicken amniotic fluid.
    Appleyard G; Davis GB
    J Gen Virol; 1983 Apr; 64 (Pt 4)():813-23. PubMed ID: 6300304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteolytic activation of vaccinia virus for the penetration phase of infection.
    Ichihashi Y; Oie M
    Virology; 1982 Jan; 116(1):297-305. PubMed ID: 7064342
    [No Abstract]   [Full Text] [Related]  

  • 6. The punctate sites of accumulation of vaccinia virus early proteins are precursors of sites of viral DNA synthesis.
    Domi A; Beaud G
    J Gen Virol; 2000 May; 81(Pt 5):1231-5. PubMed ID: 10769065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific secretion of polypeptides from cells infected with vaccinia virus.
    McCrae MA; Pennington TH
    J Virol; 1978 Dec; 28(3):828-34. PubMed ID: 731794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p65 of Gazdar murine sarcoma viruses contains antigenic determinants from all four of the murine leukemia virus (MuLV) gag polypeptides (p15, p12, p30, and p10) and can be cleaved in vitro by the MuLV proteolytic activity.
    Yoshinaka Y; Luftig RB
    Virology; 1982 Apr; 118(2):380-8. PubMed ID: 6178211
    [No Abstract]   [Full Text] [Related]  

  • 9. In vitro cleavage of Pr65gag by the Moloney murine leukaemia virus proteolytic activity yields p30 whose NH2-terminal sequence is identical to virion p30.
    Yoshinaka Y; Shames RB; Luftig RB; Smythers GW; Oroszlan S
    J Gen Virol; 1985 Feb; 66 ( Pt 2)():379-83. PubMed ID: 2578553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccinia virus intracellular DNA-protein complex: biochemical characteristics of associated protein.
    Polisky B; Kates J
    Virology; 1972 Jul; 49(1):168-79. PubMed ID: 4261046
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of some proteolytic enzymes on the plaque titer of vaccinia and rabbitpox viruses.
    Kim KS; Dalton D; Sharp DG
    Virology; 1969 Aug; 38(4):503-11. PubMed ID: 5803943
    [No Abstract]   [Full Text] [Related]  

  • 12. Modification of vaccinia virus penetration proteins analyzed by monoclonal antibodies.
    Oie M; Ichihashi Y
    Virology; 1987 Apr; 157(2):449-59. PubMed ID: 2435058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccinia virus morphogenesis: a comparison of virus-induced antigens and polypeptides.
    Pennington TH
    J Gen Virol; 1973 Apr; 19(1):65-79. PubMed ID: 4205277
    [No Abstract]   [Full Text] [Related]  

  • 14. Lymphocytic choriomeningitis virus. VII. Structural alterations of the virion by treatment with proteolytic enzymes without loss of infectivity.
    Bruns M; Lehmann-Grube F
    J Gen Virol; 1984 Aug; 65 ( Pt 8)():1431-5. PubMed ID: 6379102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The vaccinia virus 39-kDa protein forms a stable complex with the p4a/4a major core protein early in morphogenesis.
    Risco C; Rodríguez JR; Demkowicz W; Heljasvaara R; Carrascosa JL; Esteban M; Rodríguez D
    Virology; 1999 Dec; 265(2):375-86. PubMed ID: 10600608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Proteolytic processing of viral and bacterial proteins and its potentials in controlled modification for vaccine design].
    Zhirnov OP
    Mol Gen Mikrobiol Virusol; 1986 Aug; (8):3-8. PubMed ID: 3537769
    [No Abstract]   [Full Text] [Related]  

  • 17. Functional differences between the external and protoplasmic surfaces of plasma membranes in activating vaccinia virus infectivity.
    Ichihashi Y; Oie M
    Virology; 1982 Oct; 122(2):290-6. PubMed ID: 7147707
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of various proteases on the glycoprotein composition and the infectivity of influenza C virus.
    Sugawara K; Ohuchi M; Nakamura K; Homma M
    Arch Virol; 1981; 68(2):147-51. PubMed ID: 7018464
    [No Abstract]   [Full Text] [Related]  

  • 19. [The phenomenon of proteolytic activation of myxoviruses and a new strategy for treating viral diseases].
    Zhirnov OP
    Vopr Virusol; 1983; 28(4):9-21. PubMed ID: 6314677
    [No Abstract]   [Full Text] [Related]  

  • 20. Biogenesis of poxviruses: analysis of the morphogenetic sequence using a conditional lethal mutant defective in envelope self-assembly.
    Stern W; Pogo BG; Dales S
    Proc Natl Acad Sci U S A; 1977 May; 74(5):2162-6. PubMed ID: 194248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.